Impavido is used to treat Leishmaniasis, a parasitic disease that kills up to 30,000 people a year worldwide. Miltefosine is also used to treat free living amoeba such as acanthamoeba (ie AK) …

Jun 16, 2025 · Impavido is an anti-parasitic drug used to treat leishmaniasis, a disease caused by an infection with parasites that enter the body through the bite of an infected sand fly.

Miltefosine, sold under the trade name Impavido among others, is a medication mainly used to treat leishmaniasis and free-living amoeba infections such as Naegleria fowleri and …

Apr 23, 2025 · Each IMPAVIDO capsule contains 50 mg miltefosine in an opaque, red, hard gelatin capsule. IMPAVIDO capsules are supplied in a folded peel/push-through child-resistant …

Feb 24, 2025 · Impavido is used to treat certain infections caused by leishmania parasites. Common side effects include nausea, vomiting, diarrhea, headache, loss of appetite, …

Medscape - Leishmaniasis dosing for Impavido (miltefosine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost …

Apr 23, 2025 · IMPAVIDO ® (miltefosine) oral capsules are opaque, red, hard gelatin capsules with “PLB” imprinted on the capsule body and “MILT 50” imprinted on the cap using a white ink.

May 24, 2022 · Learn about Impavido (miltefosine) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.

Impavido is an antileishmanial drug used to treat visceral (affects internal organs), cutaneous (affects skin) and mucosal (affects nose, mouth) leishmaniasis.

Mar 28, 2025 · Impavido (Miltefosine Capsules) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and …